Industry Research Reports

Home > Reports > Service & Software > Spatial Transcriptomics Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Spatial Transcriptomics Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-18

Pages: 115 Pages

Report ld: 6977908

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Spatial Transcriptomics Platform Market Size(US$)

CAGR 2026-2032

14.6%

Market Size,2032

USD 1,185

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 523 million

Market Forecast in 2032(Value)

US$ 1,185 million

CAGR

14.6%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Spatial Transcriptomics Platform was estimated to be worth US$ 455 million in 2025 and is projected to reach US$ 1185 million, growing at a CAGR of 14.6% from 2026 to 2032.

Spatial transcriptomics platforms combine instruments, reagents and consumables, library-preparation workflows, and software to localize and quantify RNA expression in tissue sections while preserving morphology and spatial coordinates. They mainly use spatial barcoding and sequencing, in situ hybridization imaging, in situ sequencing, or region-of-interest digital profiling, and can provide whole-transcriptome or targeted gene measurements integrated with pathology images, cell segmentation, and protein-marker data. Key purchasing parameters include spatial resolution, transcript coverage, sensitivity, capture area, sample compatibility, throughput per run, automation, and data-analysis capability. Primary users include research institutions, core facilities, biopharmaceutical companies, and translational medicine centers. The blended gross margin is approximately 60%.

Research on tumor microenvironments, brain-region cell atlases, embryonic development, immune inflammation, and drug mechanisms requires gene-expression measurements linked to tissue location. This is moving spatial transcriptomics from small validation experiments toward larger, standardized projects. Growing interest in archived pathology samples and the need for spatial evidence in target discovery, patient stratification, and pharmacodynamic assessment are increasing demand for FFPE-compatible, high-throughput, and reproducible workflows.

Competition centers on spatial resolution, gene plex, transcript-detection sensitivity, effective imaging or capture area, sample compatibility, run time, and cost per sample. Sequencing-based platforms are strongest in whole-transcriptome discovery, while imaging-based platforms emphasize single-cell and subcellular localization. Leading suppliers are integrating instruments, reagents, panel design, image processing, cell segmentation, and cloud analytics into closed workflows. Development priorities include larger tissue areas, higher gene throughput, same-section RNA and protein detection, automated sample handling, and cross-platform data standardization.

North America and Europe continue to concentrate major core facilities, pharmaceutical customers, and premium instrument installations, while China and the wider Asia-Pacific region are expanding through local spatial-omics technologies, sequencing infrastructure, and translational research investment. Opportunities include oncology translational studies, neuroscience, tissue-atlas programs, drug-response databases, and clinical sample cohorts. Key risks include sample-preparation variation, batch effects, data and computing costs, inconsistent analytical algorithms, platform lock-in, and volatility in research budgets.

This report provides a comprehensive view of the global market for Spatial Transcriptomics Platform, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Spatial Transcriptomics Platform market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Spatial Transcriptomics Platform.

MARKET SEGMENTATION

By Company

10x Genomics
Bruker
Vizgen
STOmics
Curio Bioscience
Resolve Biosciences
Bio-Techne
Miltenyi Biotec
SeekGene
BMKMANU
CapitalBio Technology
Dynamic Biosystems
M20 Genomics
Singleron Biotechnologies
AtlasXomics

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Sequencing-Based Spatial Barcoding Platforms
Imaging-Based in Situ Hybridization Platforms
In Situ Sequencing Platforms
Region-of-Interest Digital Profiling Platforms
Spatial Single-Nucleus Sequencing Platforms
Other or Hybrid Platforms

Segment by Application

Oncology Research
Neuroscience Research
Developmental and Regenerative Biology
Immunology and Infectious Disease
Organ Physiology and Metabolic Disease
Other Life Science Research

Segment by Category

Region-Level Resolution (>100 μm)
Spot-Level Resolution (20–100 μm)
Near-Cellular Resolution (5–<20 μm)
Single-Cell Resolution (1–<5 μm)
Subcellular Resolution (<1 μm)

Segment by Division

Whole-Transcriptome Profiling
Large Targeted Panels (≥1,000 Genes)
Medium Targeted Panels (100–999 Genes)
Small Targeted Panels (<100 Genes)

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Spatial Transcriptomics Platform companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Spatial Transcriptomics Platform revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Spatial Transcriptomics Platform revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Spatial Transcriptomics Platform Product Introduction

1.2 Global Spatial Transcriptomics Platform Market Size Forecast (2021–2032)

1.3 Spatial Transcriptomics Platform Market Trends & Drivers

1.3.1 Spatial Transcriptomics Platform Industry Trends

1.3.2 Spatial Transcriptomics Platform Market Drivers & Opportunities

1.3.3 Spatial Transcriptomics Platform Market Challenges

1.3.4 Spatial Transcriptomics Platform Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Spatial Transcriptomics Platform Players Revenue Ranking (2025)

2.2 Global Spatial Transcriptomics Platform Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Spatial Transcriptomics Platform Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Spatial Transcriptomics Platform

2.6 Spatial Transcriptomics Platform Market Competitive Analysis

2.6.1 Spatial Transcriptomics Platform Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Spatial Transcriptomics Platform Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Spatial Transcriptomics Platform revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Spatial Transcriptomics Platform Market Classification

3.1 Introduction by Type

3.1.1 Sequencing-Based Spatial Barcoding Platforms

3.1.2 Imaging-Based in Situ Hybridization Platforms

3.1.3 In Situ Sequencing Platforms

3.1.4 Region-of-Interest Digital Profiling Platforms

3.1.5 Spatial Single-Nucleus Sequencing Platforms

3.1.6 Other or Hybrid Platforms

3.1.7 Global Spatial Transcriptomics Platform Sales Value by Type

3.1.7.1 Global Spatial Transcriptomics Platform Sales Value by Type (2021 vs 2025 vs 2032)

3.1.7.2 Global Spatial Transcriptomics Platform Sales Value, by Type (2021–2032)

3.1.7.3 Global Spatial Transcriptomics Platform Sales Value, by Type (%), 2021–2032

3.2 Introduction by Spatial Resolution

3.2.1 Region-Level Resolution (>100 μm)

3.2.2 Spot-Level Resolution (20–100 μm)

3.2.3 Near-Cellular Resolution (5–<20 μm)

3.2.4 Single-Cell Resolution (1–<5 μm)

3.2.5 Subcellular Resolution (<1 μm)

3.2.6 Global Spatial Transcriptomics Platform Sales Value by Spatial Resolution

3.2.6.1 Global Spatial Transcriptomics Platform Sales Value by Spatial Resolution (2021 vs 2025 vs 2032)

3.2.6.2 Global Spatial Transcriptomics Platform Sales Value, by Spatial Resolution (2021–2032)

3.2.6.3 Global Spatial Transcriptomics Platform Sales Value, by Spatial Resolution (%), 2021–2032

3.3 Introduction by Transcriptome Coverage

3.3.1 Whole-Transcriptome Profiling

3.3.2 Large Targeted Panels (≥1,000 Genes)

3.3.3 Medium Targeted Panels (100–999 Genes)

3.3.4 Small Targeted Panels (<100 Genes)

3.3.5 Global Spatial Transcriptomics Platform Sales Value by Transcriptome Coverage

3.3.5.1 Global Spatial Transcriptomics Platform Sales Value by Transcriptome Coverage (2021 vs 2025 vs 2032)

3.3.5.2 Global Spatial Transcriptomics Platform Sales Value, by Transcriptome Coverage (2021–2032)

3.3.5.3 Global Spatial Transcriptomics Platform Sales Value, by Transcriptome Coverage (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Oncology Research

4.1.2 Neuroscience Research

4.1.3 Developmental and Regenerative Biology

4.1.4 Immunology and Infectious Disease

4.1.5 Organ Physiology and Metabolic Disease

4.1.6 Other Life Science Research

4.2 Global Spatial Transcriptomics Platform Sales Value by Application

4.2.1 Global Spatial Transcriptomics Platform Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Spatial Transcriptomics Platform Sales Value by Application (2021–2032)

4.2.3 Global Spatial Transcriptomics Platform Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Spatial Transcriptomics Platform Sales Value by Region

5.1.1 Global Spatial Transcriptomics Platform Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Spatial Transcriptomics Platform Sales Value by Region (2021–2026)

5.1.3 Global Spatial Transcriptomics Platform Sales Value by Region (2027–2032)

5.1.4 Global Spatial Transcriptomics Platform Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Spatial Transcriptomics Platform Sales Value, 2021–2032

5.2.2 North America Spatial Transcriptomics Platform Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Spatial Transcriptomics Platform Sales Value, 2021–2032

5.3.2 Europe Spatial Transcriptomics Platform Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Spatial Transcriptomics Platform Sales Value, 2021–2032

5.4.2 Asia Pacific Spatial Transcriptomics Platform Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Spatial Transcriptomics Platform Sales Value, 2021–2032

5.5.2 South America Spatial Transcriptomics Platform Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Spatial Transcriptomics Platform Sales Value, 2021–2032

5.6.2 Middle East & Africa Spatial Transcriptomics Platform Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Spatial Transcriptomics Platform Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Spatial Transcriptomics Platform Sales Value, 2021–2032

6.3 United States

6.3.1 United States Spatial Transcriptomics Platform Sales Value, 2021–2032

6.3.2 United States Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Spatial Transcriptomics Platform Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Spatial Transcriptomics Platform Sales Value, 2021–2032

6.4.2 Europe Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Spatial Transcriptomics Platform Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Spatial Transcriptomics Platform Sales Value, 2021–2032

6.5.2 China Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

6.5.3 China Spatial Transcriptomics Platform Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Spatial Transcriptomics Platform Sales Value, 2021–2032

6.6.2 Japan Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Spatial Transcriptomics Platform Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Spatial Transcriptomics Platform Sales Value, 2021–2032

6.7.2 South Korea Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Spatial Transcriptomics Platform Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Spatial Transcriptomics Platform Sales Value, 2021–2032

6.8.2 Southeast Asia Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Spatial Transcriptomics Platform Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Spatial Transcriptomics Platform Sales Value, 2021–2032

6.9.2 India Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

6.9.3 India Spatial Transcriptomics Platform Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 10x Genomics

7.1.1 10x Genomics Profile

7.1.2 10x Genomics Main Business

7.1.3 10x Genomics Spatial Transcriptomics Platform Products, Services, and Solutions

7.1.4 10x Genomics Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.1.5 10x Genomics Recent Developments

7.2 Bruker

7.2.1 Bruker Profile

7.2.2 Bruker Main Business

7.2.3 Bruker Spatial Transcriptomics Platform Products, Services, and Solutions

7.2.4 Bruker Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.2.5 Bruker Recent Developments

7.3 Vizgen

7.3.1 Vizgen Profile

7.3.2 Vizgen Main Business

7.3.3 Vizgen Spatial Transcriptomics Platform Products, Services, and Solutions

7.3.4 Vizgen Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.3.5 Vizgen Recent Developments

7.4 STOmics

7.4.1 STOmics Profile

7.4.2 STOmics Main Business

7.4.3 STOmics Spatial Transcriptomics Platform Products, Services, and Solutions

7.4.4 STOmics Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.4.5 STOmics Recent Developments

7.5 Curio Bioscience

7.5.1 Curio Bioscience Profile

7.5.2 Curio Bioscience Main Business

7.5.3 Curio Bioscience Spatial Transcriptomics Platform Products, Services, and Solutions

7.5.4 Curio Bioscience Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.5.5 Curio Bioscience Recent Developments

7.6 Resolve Biosciences

7.6.1 Resolve Biosciences Profile

7.6.2 Resolve Biosciences Main Business

7.6.3 Resolve Biosciences Spatial Transcriptomics Platform Products, Services, and Solutions

7.6.4 Resolve Biosciences Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.6.5 Resolve Biosciences Recent Developments

7.7 Bio-Techne

7.7.1 Bio-Techne Profile

7.7.2 Bio-Techne Main Business

7.7.3 Bio-Techne Spatial Transcriptomics Platform Products, Services, and Solutions

7.7.4 Bio-Techne Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.7.5 Bio-Techne Recent Developments

7.8 Miltenyi Biotec

7.8.1 Miltenyi Biotec Profile

7.8.2 Miltenyi Biotec Main Business

7.8.3 Miltenyi Biotec Spatial Transcriptomics Platform Products, Services, and Solutions

7.8.4 Miltenyi Biotec Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.8.5 Miltenyi Biotec Recent Developments

7.9 SeekGene

7.9.1 SeekGene Profile

7.9.2 SeekGene Main Business

7.9.3 SeekGene Spatial Transcriptomics Platform Products, Services, and Solutions

7.9.4 SeekGene Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.9.5 SeekGene Recent Developments

7.10 BMKMANU

7.10.1 BMKMANU Profile

7.10.2 BMKMANU Main Business

7.10.3 BMKMANU Spatial Transcriptomics Platform Products, Services, and Solutions

7.10.4 BMKMANU Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.10.5 BMKMANU Recent Developments

7.11 CapitalBio Technology

7.11.1 CapitalBio Technology Profile

7.11.2 CapitalBio Technology Main Business

7.11.3 CapitalBio Technology Spatial Transcriptomics Platform Products, Services, and Solutions

7.11.4 CapitalBio Technology Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.11.5 CapitalBio Technology Recent Developments

7.12 Dynamic Biosystems

7.12.1 Dynamic Biosystems Profile

7.12.2 Dynamic Biosystems Main Business

7.12.3 Dynamic Biosystems Spatial Transcriptomics Platform Products, Services, and Solutions

7.12.4 Dynamic Biosystems Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.12.5 Dynamic Biosystems Recent Developments

7.13 M20 Genomics

7.13.1 M20 Genomics Profile

7.13.2 M20 Genomics Main Business

7.13.3 M20 Genomics Spatial Transcriptomics Platform Products, Services, and Solutions

7.13.4 M20 Genomics Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.13.5 M20 Genomics Recent Developments

7.14 Singleron Biotechnologies

7.14.1 Singleron Biotechnologies Profile

7.14.2 Singleron Biotechnologies Main Business

7.14.3 Singleron Biotechnologies Spatial Transcriptomics Platform Products, Services, and Solutions

7.14.4 Singleron Biotechnologies Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.14.5 Singleron Biotechnologies Recent Developments

7.15 AtlasXomics

7.15.1 AtlasXomics Profile

7.15.2 AtlasXomics Main Business

7.15.3 AtlasXomics Spatial Transcriptomics Platform Products, Services, and Solutions

7.15.4 AtlasXomics Spatial Transcriptomics Platform Revenue (US$ Million), 2021–2026

7.15.5 AtlasXomics Recent Developments

8 Industry Chain Analysis

8.1 Spatial Transcriptomics Platform Value Chain

8.2 Spatial Transcriptomics Platform Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Spatial Transcriptomics Platform Sales Model

8.5.2 Sales Channels

8.5.3 Spatial Transcriptomics Platform Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Spatial Transcriptomics Platform Market Trends

Table 2. Spatial Transcriptomics Platform Market Drivers & Opportunities

Table 3. Spatial Transcriptomics Platform Market Challenges

Table 4. Spatial Transcriptomics Platform Market Restraints

Table 5. Global Spatial Transcriptomics Platform Revenue by Company (US$ Million), 2021–2026

Table 6. Global Spatial Transcriptomics Platform Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Spatial Transcriptomics Platform Product Type

Table 9. Key Companies General Availability (GA) Timeline for Spatial Transcriptomics Platform

Table 10. Global Spatial Transcriptomics Platform Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Spatial Transcriptomics Platform revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Spatial Transcriptomics Platform Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Spatial Transcriptomics Platform Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Spatial Transcriptomics Platform Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Spatial Transcriptomics Platform Sales Market Share in Value by Type (2021–2026)

Table 17. Global Spatial Transcriptomics Platform Sales Market Share in Value by Type (2027–2032)

Table 18. Global Spatial Transcriptomics Platform Sales Value by Spatial Resolution: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Spatial Transcriptomics Platform Sales Value by Spatial Resolution (US$ Million), 2021–2026

Table 20. Global Spatial Transcriptomics Platform Sales Value by Spatial Resolution (US$ Million), 2027–2032

Table 21. Global Spatial Transcriptomics Platform Sales Market Share in Value by Spatial Resolution (2021–2026)

Table 22. Global Spatial Transcriptomics Platform Sales Market Share in Value by Spatial Resolution (2027–2032)

Table 23. Global Spatial Transcriptomics Platform Sales Value by Transcriptome Coverage: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global Spatial Transcriptomics Platform Sales Value by Transcriptome Coverage (US$ Million), 2021–2026

Table 25. Global Spatial Transcriptomics Platform Sales Value by Transcriptome Coverage (US$ Million), 2027–2032

Table 26. Global Spatial Transcriptomics Platform Sales Market Share in Value by Transcriptome Coverage (2021–2026)

Table 27. Global Spatial Transcriptomics Platform Sales Market Share in Value by Transcriptome Coverage (2027–2032)

Table 28. Global Spatial Transcriptomics Platform Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Spatial Transcriptomics Platform Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Spatial Transcriptomics Platform Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Spatial Transcriptomics Platform Sales Market Share in Value by Application (2021–2026)

Table 32. Global Spatial Transcriptomics Platform Sales Market Share in Value by Application (2027–2032)

Table 33. Global Spatial Transcriptomics Platform Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global Spatial Transcriptomics Platform Sales Value by Region (US$ Million), 2021–2026

Table 35. Global Spatial Transcriptomics Platform Sales Value by Region (US$ Million), 2027–2032

Table 36. Global Spatial Transcriptomics Platform Sales Value by Region (%), 2021–2026

Table 37. Global Spatial Transcriptomics Platform Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions Spatial Transcriptomics Platform Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions Spatial Transcriptomics Platform Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions Spatial Transcriptomics Platform Sales Value, (US$ Million), 2027–2032

Table 41. 10x Genomics Basic Information List

Table 42. 10x Genomics Description and Business Overview

Table 43. 10x Genomics Spatial Transcriptomics Platform Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of 10x Genomics (2021–2026)

Table 45. 10x Genomics Recent Developments

Table 46. Bruker Basic Information List

Table 47. Bruker Description and Business Overview

Table 48. Bruker Spatial Transcriptomics Platform Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of Bruker (2021–2026)

Table 50. Bruker Recent Developments

Table 51. Vizgen Basic Information List

Table 52. Vizgen Description and Business Overview

Table 53. Vizgen Spatial Transcriptomics Platform Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of Vizgen (2021–2026)

Table 55. Vizgen Recent Developments

Table 56. STOmics Basic Information List

Table 57. STOmics Description and Business Overview

Table 58. STOmics Spatial Transcriptomics Platform Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of STOmics (2021–2026)

Table 60. STOmics Recent Developments

Table 61. Curio Bioscience Basic Information List

Table 62. Curio Bioscience Description and Business Overview

Table 63. Curio Bioscience Spatial Transcriptomics Platform Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of Curio Bioscience (2021–2026)

Table 65. Curio Bioscience Recent Developments

Table 66. Resolve Biosciences Basic Information List

Table 67. Resolve Biosciences Description and Business Overview

Table 68. Resolve Biosciences Spatial Transcriptomics Platform Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of Resolve Biosciences (2021–2026)

Table 70. Resolve Biosciences Recent Developments

Table 71. Bio-Techne Basic Information List

Table 72. Bio-Techne Description and Business Overview

Table 73. Bio-Techne Spatial Transcriptomics Platform Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of Bio-Techne (2021–2026)

Table 75. Bio-Techne Recent Developments

Table 76. Miltenyi Biotec Basic Information List

Table 77. Miltenyi Biotec Description and Business Overview

Table 78. Miltenyi Biotec Spatial Transcriptomics Platform Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of Miltenyi Biotec (2021–2026)

Table 80. Miltenyi Biotec Recent Developments

Table 81. SeekGene Basic Information List

Table 82. SeekGene Description and Business Overview

Table 83. SeekGene Spatial Transcriptomics Platform Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of SeekGene (2021–2026)

Table 85. SeekGene Recent Developments

Table 86. BMKMANU Basic Information List

Table 87. BMKMANU Description and Business Overview

Table 88. BMKMANU Spatial Transcriptomics Platform Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of BMKMANU (2021–2026)

Table 90. BMKMANU Recent Developments

Table 91. CapitalBio Technology Basic Information List

Table 92. CapitalBio Technology Description and Business Overview

Table 93. CapitalBio Technology Spatial Transcriptomics Platform Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of CapitalBio Technology (2021–2026)

Table 95. CapitalBio Technology Recent Developments

Table 96. Dynamic Biosystems Basic Information List

Table 97. Dynamic Biosystems Description and Business Overview

Table 98. Dynamic Biosystems Spatial Transcriptomics Platform Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of Dynamic Biosystems (2021–2026)

Table 100. Dynamic Biosystems Recent Developments

Table 101. M20 Genomics Basic Information List

Table 102. M20 Genomics Description and Business Overview

Table 103. M20 Genomics Spatial Transcriptomics Platform Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of M20 Genomics (2021–2026)

Table 105. M20 Genomics Recent Developments

Table 106. Singleron Biotechnologies Basic Information List

Table 107. Singleron Biotechnologies Description and Business Overview

Table 108. Singleron Biotechnologies Spatial Transcriptomics Platform Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of Singleron Biotechnologies (2021–2026)

Table 110. Singleron Biotechnologies Recent Developments

Table 111. AtlasXomics Basic Information List

Table 112. AtlasXomics Description and Business Overview

Table 113. AtlasXomics Spatial Transcriptomics Platform Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of AtlasXomics (2021–2026)

Table 115. AtlasXomics Recent Developments

Table 116. Revenue (US$ Million) in Spatial Transcriptomics Platform Business of Company 40 (2021–2026)

Table 117. Company 40 Recent Developments

Table 118. Key Raw Materials Lists

Table 119. Key Suppliers of Raw Materials Lists

Table 120. Spatial Transcriptomics Platform Downstream Customers

Table 121. Spatial Transcriptomics Platform Distributors List

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

List of Figures

Figure 1. Spatial Transcriptomics Platform Product Picture

Figure 2. Global Spatial Transcriptomics Platform Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 4. Spatial Transcriptomics Platform Report Years Considered

Figure 5. Global Spatial Transcriptomics Platform Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Spatial Transcriptomics Platform Revenue in 2025

Figure 7. Spatial Transcriptomics Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Sequencing-Based Spatial Barcoding Platforms Picture

Figure 9. Imaging-Based in Situ Hybridization Platforms Picture

Figure 10. In Situ Sequencing Platforms Picture

Figure 11. Region-of-Interest Digital Profiling Platforms Picture

Figure 12. Spatial Single-Nucleus Sequencing Platforms Picture

Figure 13. Other or Hybrid Platforms Picture

Figure 14. Global Spatial Transcriptomics Platform Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Spatial Transcriptomics Platform Sales Value Market Share by Type, 2025 & 2032

Figure 16. Region-Level Resolution (>100 μm) Picture

Figure 17. Spot-Level Resolution (20–100 μm) Picture

Figure 18. Near-Cellular Resolution (5–<20 μm) Picture

Figure 19. Single-Cell Resolution (1–<5 μm) Picture

Figure 20. Subcellular Resolution (<1 μm) Picture

Figure 21. Global Spatial Transcriptomics Platform Sales Value by Spatial Resolution (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Spatial Transcriptomics Platform Sales Value Market Share by Spatial Resolution, 2025 & 2032

Figure 23. Whole-Transcriptome Profiling Picture

Figure 24. Large Targeted Panels (≥1,000 Genes) Picture

Figure 25. Medium Targeted Panels (100–999 Genes) Picture

Figure 26. Small Targeted Panels (<100 Genes) Picture

Figure 27. Global Spatial Transcriptomics Platform Sales Value by Transcriptome Coverage (US$ Million), 2021 vs 2025 vs 2032

Figure 28. Global Spatial Transcriptomics Platform Sales Value Market Share by Transcriptome Coverage, 2025 & 2032

Figure 29. Product Picture of Oncology Research

Figure 30. Product Picture of Neuroscience Research

Figure 31. Product Picture of Developmental and Regenerative Biology

Figure 32. Product Picture of Immunology and Infectious Disease

Figure 33. Product Picture of Organ Physiology and Metabolic Disease

Figure 34. Product Picture of Other Life Science Research

Figure 35. Global Spatial Transcriptomics Platform Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 36. Global Spatial Transcriptomics Platform Sales Value Market Share by Application, 2025 & 2032

Figure 37. North America Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 38. North America Spatial Transcriptomics Platform Sales Value by Country (%), 2025 vs 2032

Figure 39. Europe Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 40. Europe Spatial Transcriptomics Platform Sales Value by Country (%), 2025 vs 2032

Figure 41. Asia Pacific Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 42. Asia Pacific Spatial Transcriptomics Platform Sales Value by Subregion (%), 2025 vs 2032

Figure 43. South America Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 44. South America Spatial Transcriptomics Platform Sales Value by Country (%), 2025 vs 2032

Figure 45. Middle East & Africa Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 46. Middle East & Africa Spatial Transcriptomics Platform Sales Value by Country (%), 2025 vs 2032

Figure 47. Key Countries/Regions Spatial Transcriptomics Platform Sales Value (%), 2021–2032

Figure 48. United States Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 49. United States Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

Figure 50. United States Spatial Transcriptomics Platform Sales Value by Application (%), 2025 vs 2032

Figure 51. Europe Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 52. Europe Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

Figure 53. Europe Spatial Transcriptomics Platform Sales Value by Application (%), 2025 vs 2032

Figure 54. China Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 55. China Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

Figure 56. China Spatial Transcriptomics Platform Sales Value by Application (%), 2025 vs 2032

Figure 57. Japan Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 58. Japan Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

Figure 59. Japan Spatial Transcriptomics Platform Sales Value by Application (%), 2025 vs 2032

Figure 60. South Korea Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 61. South Korea Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

Figure 62. South Korea Spatial Transcriptomics Platform Sales Value by Application (%), 2025 vs 2032

Figure 63. Southeast Asia Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 64. Southeast Asia Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

Figure 65. Southeast Asia Spatial Transcriptomics Platform Sales Value by Application (%), 2025 vs 2032

Figure 66. India Spatial Transcriptomics Platform Sales Value (US$ Million), 2021–2032

Figure 67. India Spatial Transcriptomics Platform Sales Value by Type (%), 2025 vs 2032

Figure 68. India Spatial Transcriptomics Platform Sales Value by Application (%), 2025 vs 2032

Figure 69. Spatial Transcriptomics Platform Value Chain

Figure 70. Spatial Transcriptomics Platform Cost Structure

Figure 71. Channels of Distribution (Direct Sales, and Distribution)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Spatial Transcriptomics Platform market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Spatial Transcriptomics Platform market is 14.6% 2026 to 2032.

Which region is expected to have the highest market share? shouQi

What was the global market size of Spatial Transcriptomics Platform in 2032? shouQi

Which companies rank high in the global Spatial Transcriptomics Platform market? shouQi

What was the global market size of Spatial Transcriptomics Platform in 2026? shouQi

Related Reports

Global Spatial Transcriptomics Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spatial Transcriptomics Platform market size was US$ 455 million in 2025 and is forecast to reach a readjusted size of US$ 1185 million by 2032 with a CAGR of 14.6% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 116
USD 4250.00
(Single User License)
Global Spatial Transcriptomics Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Transcriptomics Platform market is projected to grow from US$ 455 million in 2025 to US$ 1185 million by 2032, at a CAGR of 14.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 141
USD 4900.00
(Single User License)
Global Spatial Transcriptomics Platform Market Research Report 2026
The global Spatial Transcriptomics Platform market was valued at US$ 455 million in 2025 and is anticipated to reach US$ 1185 million by 2032, at a CAGR of 14.6% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 113
USD 2900.00
(Single User License)

Global Spatial Transcriptomics Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spatial Transcriptomics Platform market size was US$ 455 million in 2025 and is forecast to reach a readjusted size of US$ 1185 million by 2032 with a CAGR of 14.6% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 116
USD 4250.00 (Single User License)
Global Spatial Transcriptomics Platform Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Transcriptomics Platform market is projected to grow from US$ 455 million in 2025 to US$ 1185 million by 2032, at a CAGR of 14.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 141
USD 4900.00 (Single User License)
Global Spatial Transcriptomics Platform Market Research Report 2026
The global Spatial Transcriptomics Platform market was valued at US$ 455 million in 2025 and is anticipated to reach US$ 1185 million by 2032, at a CAGR of 14.6% from 2026 to 2032.
Published: 2026-07-18
Pages: 113
USD 2900.00 (Single User License)